Avenciguat (BI 685509): sGC activator | SSc Indication: Systemic sclerosis This compound is under investigation, further information will be available soon. Fast Track Designation granted by the U.S. Food and Drug Administration Partnering inquiries Join our team Additional links Immunology research Partnering in Immunology
